Ethicon endomechanical8/31/2023 ![]() “Surgeons will now be able to have the same confidence in laparoscopic suturing that they have always had with traditional procedures using Ethicon products.” ![]() Niels-Derrek Schmitz, Franchise Medical Director for Ethicon. “With the patient’s health at the forefront of our thinking, we aimed to introduce a suturing device that will help reduce the margin of error in minimally-invasive surgery,” said Dr. The suturing precision is deployed by enabling surgeons to reach the desired angle, control bites, and secure knots, as well as to have maximum control of the needle during suturing and knot tying, which may reduce the risk of needle loss. ProxiSure Suturing Device features wrist-like maneuverability and curved needle in an advanced suturing device that improves suturing precision in tight spaces. The addition of ProxiSure builds upon Ethicon’s expansive portfolio of suturing technologies while establishing a new standard of excellence in laparoscopic suturing. Ethicon has been a steadfast champion of minimally-invasive surgery, delivering innovative solutions and support services that promote greater procedural expertise, improved hospital outcomes, and better patient care. Wednesday, August 23, 2017, 12:00 Hrs Įthicon, part of the Johnson & Johnson Medical Devices Companies, announced the US launch of the ProxiSure Suturing Device, an advanced laparoscopic suturing device featuring Ethicon endomechanical, suture and curved needle technologies. Click hereĮthicon introduces advanced laparoscopic suturing device, Proxisure Suturing Device Users with questions regarding the vulnerability or the product update are advised to contact their Ethicon Endo-Surgery, LLC sales representative or Ethicon Customer Support Center at 1-877-ETHICON.You can get e-magazine links on WhatsApp. The update was made available on November 29, 2017. MITIGATIONĮthicon Endo-Surgery, LLC has contacted users and initiated a field cybersecurity update to address the vulnerability in the Ethicon Endo-Surgery Generator Gen11. DIFFICULTYĪn attacker with high skill would be able to exploit this vulnerability. No known public exploits specifically target this vulnerability. This vulnerability cannot be exploited remotely. A CVSS v3 base score of 4.8 has been assigned the CVSS vector string is (AV:P/AC:H/PR:N/UI:N/S:U/C:N/I:H/A:L).CVSS Calculator,, web site last accessed November 28, 2017. This web site will be active sometime after publication of this advisory. The security authentication mechanism used between the Ethicon Endo-Surgery Generator Gen11 and single-patient use products can be bypassed, allowing for unauthorized devices to be connected to the generator, which could result in a loss of integrity or availability.ĬVE-2017-14018NVD,, NIST uses this advisory to create the CVE web site report. IMPROPER AUTHENTICATIONCWE-287: Improper Authentication,, web site last accessed November 28, 2017. ![]() VULNERABILITY CHARACTERIZATION VULNERABILITY OVERVIEW The Ethicon Endo-Surgery Generator Gen11 is deployed across the Healthcare and Public Health sector. BACKGROUNDĮthicon Endo-Surgery, LLC is a subsidiary of Johnson & Johnson and is a U.S.-based company that maintains offices in several countries around the world. ICS-CERT recommends that organizations evaluate the impact of this vulnerability based on their operational environment and specific clinical usage. Impact to individual organizations depends on many factors that are unique to each organization.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |